Stay updated on NC410 Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.

Latest updates to the NC410 Plus Pembrolizumab Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedVersion updates show termination after Phase 1b and the posting of results for the NC410 plus Pembrolizumab trial. The history also adds updates to the study status and includes Outcome Measures in the results section.SummaryDifference0.9%

- Check15 days agoChange DetectedThe study record's change history adds a new revision entry v3.6.5; the previous revision v3.6.4 is listed under deletions, signaling an update to the version history.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows a new revision (v3.6.4) that supersedes the previous version (v3.6.3), indicating an updated page revision.SummaryDifference0.1%

- Check36 days agoChange DetectedA new version entry on 2026-07-15 adds core study sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and related areas (Oversight, Study Status, Recruitment Status) to the record. The update also introduces a Quality Control status (Has Not Concluded) and navigation items such as More Information and Document Section.SummaryDifference1%

- Check51 days agoChange DetectedA new revision entry (v3.6.3) was added to the history, replacing the previous v3.6.2 and signaling an update to the record's documentation.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and an earlier revision (v3.6.0) was removed, updating the list of published versions.SummaryDifference0.1%

Stay in the know with updates to NC410 Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.